Company intelligence
Precision AQ
About Precision AQ
Precision AQ is the commercialization partner of choice for biopharma innovators, market access leaders, and brand strategists. Trusted by all 30 of the world’s top pharmaceutical companies and leading biotechs, we specialize in turning complex data into clear, actionable strategies that accelerate access to innovation, including launching more than 450 drugs across all therapeutic areas. We believe access is enabled by evidence, empathy, and precision. We combine deep domain expertise with technology to turn fragmented data into clarity. Our global capabilities include: - Market access strategy and commercial consulting - Health economics and outcomes research (HEOR) - Medical communications - Market access marketing and omnichannel solutions - Advertising, branding, and public relations - Investor relations and external communications - Data and product solutions We help teams navigate payer, provider, and patient dynamics, delivering strategies that move markets- and lives- forward.
Verified activity
Signals from Precision AQ
11 published signals
Presence & Recognition
Precision AQ's Managing Director Lauren Westberg will attend the MedTech VISION Annual Conference on September 15 in Menlo Park, California.
Reported by Precision AQ
Research & Knowledge
Precision AQ conducted a survey showing that 73% of healthcare professionals said knowing exactly what a prior authorization requires before prescribing would be extremely or very helpful.
Reported by Precision AQ
Presence & Recognition
Precision AQ will moderate a discussion at the AVBCC Annual Summit exploring the role of NCCN and pathway organizations in shaping access decisions across the healthcare ecosystem.
Reported by Precision AQ
Presence & Recognition
Precision AQ is hosting Read Roberts, Senior Director, Product Development, and Jason McDonough, PhD, CMPP, SVP, Medical Strategy, at Fierce Pharma Week on September 16 from 10:40AM to 10:55AM.
Reported by Precision AQ
Presence & Recognition
Precision AQ will have 32 accepted posters, 2 podium presentations, 1 workshop, and 2 posters recognized among the top 5% of submissions at ISPOR Europe 2026.
Reported by Precision AQ
Research & Knowledge
Precision AQ published a Journal of Patient Centricity white paper proposing the Chief Patient Officer (CPO) function as a solution to bridge scientific maturity and healthcare system readiness across five critical features.
Reported by Precision AQ
Products & Services
Precision AQ built an IDN EHR guidance system to find hematologic malignancy patients who may have been ready for treatment escalation, resulting in 300+ patients reported within a few minutes of a report run through Epic.
Reported by Precision AQ
Presence & Recognition
Precision AQ partnered with the Franklin YMCA to assemble bicycles for local children.
Reported by Precision AQ
Research & Knowledge
Precision AQ published a white paper by Shraddha Kansagra, PharmD, BCOP on precision oncology access and the 2026 OncoGenius Biomarker Report found across 100 U.S. cancer organizations.
Reported by Precision AQ
Presence & Recognition
Precision AQ is attending Fierce Pharma Week to connect with peers and explore data-driven insights, evidence generation, market access strategy, and stakeholder engagement.
Reported by Precision AQ
Research & Knowledge
Precision AQ announced that World Labs’ Atlas is a glimpse at where AI is heading next, focusing on building, understanding, and navigating explorable 3D worlds.
Reported by Alex Teplish